SHLS Shoals Technologies Group | $11.71 -2.9% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $20.48 +6.0% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $12.69 +1.0% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |
JNJ Johnson & Johnson | $156.77 -0.9% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 3/13/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/14/2024 |
CPRX Catalyst Pharmaceuticals | $16.08 +0.1% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/14/2024 |
|
MNKD MannKind | $4.62 +3.4% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 3/15/2024 |
DESP Despegar.com | $11.19 -1.1% | 3/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/15/2024 |
SSTI SoundThinking | $15.03 -0.8% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 3/15/2024 |
MU Micron Technology | $93.78 +0.6% | 3/18/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/18/2024 |
RNA Avidity Biosciences | $23.93 -2.0% | 3/14/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Avidity Biosciences (NASDAQ:RNA) on 3/14/2024 |
FROG JFrog | $43.11 +2.2% | 3/7/2024 | Target Raised by | Cantor Fitzgerald | - | | $40.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EVGO EVgo | $2.41 -3.6% | 3/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $5.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 3/7/2024 |
ISPO Inspirato | $3.95 -2.2% | 3/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Inspirato (NASDAQ:ISPO) on 3/7/2024 |
DESP Despegar.com | $11.19 -1.1% | 3/7/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/7/2024 |
CIFR Cipher Mining | $3.95 +11.9% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/6/2024 |
NPCE NeuroPace | $12.84 -2.6% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $16.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/6/2024 |
CERS Cerus | $1.86 -2.6% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 3/6/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $360.00 -> $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.34 -1.5% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
THC Tenet Healthcare | $100.38 +1.6% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 3/5/2024 |
ACHC Acadia Healthcare | $78.15 +0.5% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 3/5/2024 |
HCA HCA Healthcare | $327.18 +1.6% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 3/5/2024 |
HCAT Health Catalyst | $7.61 -2.7% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 3/5/2024 |
RCM R1 RCM | $13.17 -2.6% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 3/5/2024 |
SGRY Surgery Partners | $27.52 -3.3% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 3/5/2024 |
TBRG TruBridge | $9.72 -3.1% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/5/2024 |
GTLB GitLab | $55.24 +3.4% | 3/5/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/5/2024 |
NVDA NVIDIA | $884.55 +0.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $900.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/4/2024 |
NXPI NXP Semiconductors | $236.62 -0.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 3/4/2024 |
TXN Texas Instruments | $169.21 -1.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 3/4/2024 |
QCOM QUALCOMM | $166.92 -0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 3/4/2024 |
TER Teradyne | $102.86 -0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/4/2024 |
STX Seagate Technology | $85.39 -0.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 3/4/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 -> $1,600.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/4/2024 |
AMAT Applied Materials | $200.73 +1.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 3/4/2024 |
AMD Advanced Micro Devices | $190.65 -0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 3/4/2024 |
KLAC KLA | $690.70 +1.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 3/4/2024 |
LRCX Lam Research | $925.28 +1.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 3/4/2024 |
ADI Analog Devices | $191.22 -2.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 3/4/2024 |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
CI The Cigna Group | $352.63 +0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $372.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/4/2024 |
PAGS PagSeguro Digital | $14.07 +1.1% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $16.00 | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 3/4/2024 |
CRNX Crinetics Pharmaceuticals | $37.93 -2.6% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/4/2024 |
RIOT Riot Platforms | $11.43 -1.5% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/4/2024 |
ETNB 89bio | $12.60 -6.8% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 3/4/2024 |
BBAI BigBear.ai | $2.21 -9.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/4/2024 |
EVLV Evolv Technologies | $3.45 -2.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/1/2024 |
PTCT PTC Therapeutics | $29.01 -1.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 3/1/2024 |
AVPT AvePoint | $7.56 +0.1% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 3/1/2024 |
SOUN SoundHound AI | $8.24 -7.5% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.60 -> $5.80 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
MVIS MicroVision | $1.78 -7.3% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.00 | Low | View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 3/1/2024 |
PFE Pfizer | $27.74 -0.7% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 3/1/2024 |
ZS Zscaler | $195.94 +1.0% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $250.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
CPRX Catalyst Pharmaceuticals | $16.08 +0.1% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $27.00 -> $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/1/2024 |
PAYO Payoneer Global | $4.50 +5.4% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Payoneer Global (NASDAQ:PAYO) on 3/1/2024 |
CPSI Computer Programs and Systems | $9.19 +3.7% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Computer Programs and Systems (NASDAQ:CPSI) on 3/1/2024 |
ORGO Organogenesis | $2.75 -3.5% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 3/1/2024 |
MIRM Mirum Pharmaceuticals | $25.98 -3.0% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/29/2024 |
SRPT Sarepta Therapeutics | $123.97 +0.7% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.71 -2.9% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $28.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
CYBR CyberArk Software | $260.92 +0.7% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 2/29/2024 |
MRK Merck & Co., Inc. | $121.44 -0.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/29/2024 |
FOLD Amicus Therapeutics | $11.58 +0.9% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 2/29/2024 |
DCGO DocGo | $3.68 +0.5% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 2/29/2024 |
ADMA ADMA Biologics | $5.94 -0.8% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 -> $8.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 2/29/2024 |
LUNR Intuitive Machines | $5.32 -3.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/29/2024 |
UHS Universal Health Services | $177.20 +1.9% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Underweight -> Underweight | $148.00 -> $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $123.41 +2.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
TDOC Teladoc Health | $15.12
| 2/29/2024 | Initiated by | Cantor Fitzgerald | Analyst S. James | Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Teladoc Health (NYSE:TDOC) on 2/29/2024 |
MNKD MannKind | $4.62 +3.4% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
ACAD ACADIA Pharmaceuticals | $18.72 +1.3% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/28/2024 |
ARRY Array Technologies | $11.94 +1.8% | 2/28/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
SSTI SoundThinking | $15.03 -0.8% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/28/2024 |
PGNY Progyny | $36.31 +3.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 2/28/2024 |
MKFG Markforged | $0.79 +5.3% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $1.45 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 2/28/2024 |
DM Desktop Metal | $0.66 +1.5% | 2/28/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $1.25 | Low | View details for Cantor Fitzgerald rating of Desktop Metal (NYSE:DM) on 2/28/2024 |
SIBN SI-BONE | $15.95 -0.6% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/27/2024 |
ACHR Archer Aviation | $4.87 -3.0% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
BBAI BigBear.ai | $2.21 -9.4% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/27/2024 |
RCKT Rocket Pharmaceuticals | $26.52 -1.1% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/27/2024 |
SGRY Surgery Partners | $27.52 -3.3% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 2/27/2024 |
GENI Genius Sports | $5.73 -1.5% | 2/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Genius Sports (NYSE:GENI) on 2/26/2024 |
BMRN BioMarin Pharmaceutical | $83.81 -0.1% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/23/2024 |
HRMY Harmony Biosciences | $31.59 -1.2% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 2/23/2024 |
WULF TeraWulf | $1.73 -2.8% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 2/23/2024 |
LUNR Intuitive Machines | $5.32 -3.1% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/23/2024 |
RIOT Riot Platforms | $11.43 -1.5% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 2/23/2024 |
RCEL AVITA Medical | $15.83 -3.7% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 2/23/2024 |
AUPH Aurinia Pharmaceuticals | $5.09 -1.5% | 2/23/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $12.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 2/23/2024 |
Central Bank Gold Heist In Progress (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
ITCI Intra-Cellular Therapies | $65.37 +0.9% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $101.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 2/23/2024 |
ORIC ORIC Pharmaceuticals | $14.68 -2.8% | 2/23/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/23/2024 |
LCID Lucid Group | $2.75 +1.9% | 2/22/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Underweight | $6.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 2/22/2024 |
ROOT Root | $59.13 +11.8% | 2/22/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Neutral -> Overweight | $9.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Root (NASDAQ:ROOT) on 2/22/2024 |
ENVX Enovix | $7.33 -6.5% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/21/2024 |
PANW Palo Alto Networks | $285.24 +1.1% | 2/21/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 -> $350.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
SPT Sprout Social | $56.62 +0.4% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 2/21/2024 |
SABR Sabre | $1.96 -1.0% | 2/21/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2024 |
ALNY Alnylam Pharmaceuticals | $147.41 -1.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/20/2024 |
AXSM Axsome Therapeutics | $72.54 -4.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/20/2024 |
BIIB Biogen | $219.40 +0.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $311.00 | Low | View details for Cantor Fitzgerald rating of Biogen (NASDAQ:BIIB) on 2/20/2024 |
JNJ Johnson & Johnson | $156.77 -0.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 2/20/2024 |
KRTX Karuna Therapeutics | $329.83
| 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $330.00 | Low | View details for Cantor Fitzgerald rating of Karuna Therapeutics (NASDAQ:KRTX) on 2/20/2024 |
LLY Eli Lilly and Company | $762.66 +1.1% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/20/2024 |
NVO Novo Nordisk A/S | $132.89 +0.4% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $140.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/20/2024 |
VRTX Vertex Pharmaceuticals | $411.38 +0.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $440.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/20/2024 |
ADI Analog Devices | $191.22 -2.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 2/20/2024 |
AMAT Applied Materials | $200.73 +1.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 2/20/2024 |
AMD Advanced Micro Devices | $190.65 -0.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 2/20/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 2/20/2024 |
KLAC KLA | $690.70 +1.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 2/20/2024 |
LRCX Lam Research | $925.28 +1.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/20/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $775.00 -> $900.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/20/2024 |
NXPI NXP Semiconductors | $236.62 -0.4% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/20/2024 |
RAPT RAPT Therapeutics | $8.33 -1.7% | 2/20/2024 | Downgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Neutral | | N/A | View details for Cantor Fitzgerald rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/20/2024 |
CGON CG Oncology | $38.11 -1.1% | 2/20/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 2/20/2024 |
CISO CISO Global | $1.30 -4.4% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight | | N/A | View details for Cantor Fitzgerald rating of CISO Global (NASDAQ:CISO) on 2/14/2024 |
RGLD Royal Gold | $110.19 -1.2% | 2/15/2024 | Downgraded by | Cantor Fitzgerald | - | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Royal Gold (NASDAQ:RGLD) on 2/15/2024 |
NNOX Nano-X Imaging | $11.38 +5.6% | 2/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 2/15/2024 |
UDMY Udemy | $11.07 +0.8% | 2/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 2/15/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 2/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $114.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/15/2024 |
ZFOX ZeroFox | $1.11 -1.8% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral | | Low | View details for Cantor Fitzgerald rating of ZeroFox (NASDAQ:ZFOX) on 2/12/2024 |
LLY Eli Lilly and Company | $762.66 +1.1% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/14/2024 |
MRK Merck & Co., Inc. | $121.44 -0.1% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/14/2024 |
NVO Novo Nordisk A/S | $132.89 +0.4% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $140.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/14/2024 |
ELV Elevance Health | $511.31 -0.3% | 2/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $547.00 -> $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 2/14/2024 |
GFS GLOBALFOUNDRIES | $52.10 +0.4% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $70.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 2/14/2024 |
SRPT Sarepta Therapeutics | $123.97 +0.7% | 2/14/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/14/2024 |
CBAY CymaBay Therapeutics | $32.46 +0.0% | 2/13/2024 | Downgraded by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Neutral | $32.50 | Low | View details for Cantor Fitzgerald rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/13/2024 |
SSYS Stratasys | $11.47 -3.6% | 2/13/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 2/13/2024 |
DDD 3D Systems | $4.34 -4.6% | 2/13/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $8.50 | Low | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 2/13/2024 |
AMAT Applied Materials | $200.73 +1.0% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 2/12/2024 |
AMD Advanced Micro Devices | $190.65 -0.2% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 2/12/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 2/12/2024 |
KLAC KLA | $690.70 +1.0% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 2/12/2024 |
LRCX Lam Research | $925.28 +1.7% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/12/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $775.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/12/2024 |
QCOM QUALCOMM | $166.92 -0.2% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/12/2024 |
TXN Texas Instruments | $169.21 -1.9% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 2/12/2024 |
ALNY Alnylam Pharmaceuticals | $147.41 -1.2% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/12/2024 |
Central Bank Gold Heist In Progress (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
ADI Analog Devices | $191.22 -2.0% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 2/12/2024 |
GTLB GitLab | $55.24 +3.4% | 2/12/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 2/12/2024 |
PANW Palo Alto Networks | $285.24 +1.1% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $280.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/12/2024 |
SSTI SoundThinking | $15.03 -0.8% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $30.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/12/2024 |
ZS Zscaler | $195.94 +1.0% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $185.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 2/12/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $240.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 2/12/2024 |
DDOG Datadog | $120.87 +0.4% | 2/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $115.00 -> $145.00 | Low | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 2/12/2024 |
FROG JFrog | $43.11 +2.2% | 2/12/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 -> $40.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 2/12/2024 |
NET Cloudflare | $94.68 +3.4% | 2/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 2/9/2024 |
THC Tenet Healthcare | $100.38 +1.6% | 2/9/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $94.00 -> $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 2/9/2024 |
MOH Molina Healthcare | $410.35 +1.5% | 2/9/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $374.00 -> $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 2/9/2024 |
CYBR CyberArk Software | $260.92 +0.7% | 2/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $210.00 -> $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 2/8/2024 |
CSGS CSG Systems International | $50.77 -0.3% | 2/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $63.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 2/8/2024 |
CVS CVS Health | $77.54 +0.2% | 2/8/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 2/8/2024 |
AGIO Agios Pharmaceuticals | $29.29 -2.2% | 2/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 2/8/2024 |
FTNT Fortinet | $67.55 +1.2% | 2/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $50.00 -> $75.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 2/7/2024 |
KE Kimball Electronics | $20.08 -1.2% | 2/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $33.00 -> $28.00 | Low | View details for Cantor Fitzgerald rating of Kimball Electronics (NASDAQ:KE) on 2/7/2024 |
GILD Gilead Sciences | $73.26 -0.6% | 2/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $80.00 -> $78.00 | Low | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 2/7/2024 |
FRSH Freshworks | $17.97 +1.1% | 2/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 2/7/2024 |
BBAI BigBear.ai | $2.21 -9.4% | 2/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/7/2024 |
ORGO Organogenesis | $2.75 -3.5% | 2/7/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 2/7/2024 |
VRTX Vertex Pharmaceuticals | $411.38 +0.9% | 2/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $440.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/6/2024 |
ZFOX ZeroFox | $1.11 -1.8% | 2/6/2024 | Downgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of ZeroFox (NASDAQ:ZFOX) on 2/6/2024 |
REGN Regeneron Pharmaceuticals | $959.92 -0.5% | 2/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $850.00 -> $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/6/2024 |
ASND Ascendis Pharma A/S | $147.06 -1.1% | 2/6/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $152.00 -> $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/6/2024 |
SMTI Sanara MedTech | $36.41 -1.6% | 2/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 2/6/2024 |
JNJ Johnson & Johnson | $156.77 -0.9% | 2/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 2/6/2024 |
SYM Symbotic | $45.13 -0.5% | 2/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 2/6/2024 |
NXPI NXP Semiconductors | $236.62 -0.4% | 2/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $260.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/6/2024 |
MRK Merck & Co., Inc. | $121.44 -0.1% | 2/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/5/2024 |
LCTX Lineage Cell Therapeutics | $1.17 -9.3% | 2/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | N/A | View details for Cantor Fitzgerald rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/5/2024 |
CI The Cigna Group | $352.63 +0.2% | 2/5/2024 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | $334.00 -> $372.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 2/5/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $240.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 2/2/2024 |
CRNX Crinetics Pharmaceuticals | $37.93 -2.6% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/2/2024 |
COUR Coursera | $14.37 +1.3% | 2/2/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 2/2/2024 |
INTC Intel | $42.71 +0.2% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 2/2/2024 |
ELV Elevance Health | $511.31 -0.3% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $547.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 2/2/2024 |
ACAD ACADIA Pharmaceuticals | $18.72 +1.3% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/2/2024 |
TXN Texas Instruments | $169.21 -1.9% | 2/2/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 2/2/2024 |
RDW Redwire | $3.50 +4.5% | 2/2/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 2/2/2024 |
NXT Nextracker | $59.16 -0.6% | 2/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $52.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of Nextracker (NASDAQ:NXT) on 2/1/2024 |
QCOM QUALCOMM | $166.92 -0.2% | 2/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/1/2024 |
NVO Novo Nordisk A/S | $132.89 +0.4% | 2/1/2024 | Target Raised by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $120.00 -> $140.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/1/2024 |
LLY Eli Lilly and Company | $762.66 +1.1% | 2/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/1/2024 |
RCKT Rocket Pharmaceuticals | $26.52 -1.1% | 1/31/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 1/31/2024 |
TER Teradyne | $102.86 -0.2% | 1/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/31/2024 |
PFE Pfizer | $27.74 -0.7% | 1/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 1/31/2024 |
CYBR CyberArk Software | $260.92 +0.7% | 1/31/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $210.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 1/31/2024 |
ZS Zscaler | $195.94 +1.0% | 1/31/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $185.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 1/31/2024 |
EVEX EVE | $5.43
| 1/30/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $7.00 | Low | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 1/30/2024 |
They said crypto was dead. It went up 100X. (Ad) Bitcoin’s haters are out again.
Despite the price doubling in the last six months alone…
That hasn’t stopped the experts from piling on.
Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews.
JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.”
But when it comes to cryptos, these are exactly the people you shouldn’t listen to.
They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. |
ADI Analog Devices | $191.22 -2.0% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 1/29/2024 |
AMD Advanced Micro Devices | $190.65 -0.2% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 1/29/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 1/29/2024 |
KLAC KLA | $690.70 +1.0% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/29/2024 |
LRCX Lam Research | $925.28 +1.7% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/29/2024 |
NVDA NVIDIA | $884.55 +0.7% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $775.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/29/2024 |
ACHR Archer Aviation | $4.87 -3.0% | 1/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 1/29/2024 |
PTCT PTC Therapeutics | $29.01 -1.8% | 1/26/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 1/26/2024 |
HUM Humana | $347.19 -0.3% | 1/26/2024 | Downgraded by | Cantor Fitzgerald | - | Overweight -> Neutral | $597.00 -> $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 1/26/2024 |
ELV Elevance Health | $511.31 -0.3% | 1/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $547.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/25/2024 |
BITF Bitfarms | $2.23 -1.3% | 1/25/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 1/25/2024 |
CIFR Cipher Mining | $3.95 +11.9% | 1/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 1/25/2024 |
VRTX Vertex Pharmaceuticals | $411.38 +0.9% | 1/24/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $415.00 -> $440.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/24/2024 |
JNJ Johnson & Johnson | $156.77 -0.9% | 1/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 1/23/2024 |
LLY Eli Lilly and Company | $762.66 +1.1% | 1/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 1/23/2024 |
WDC Western Digital | $59.31 -0.8% | 1/23/2024 | Initiated by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/23/2024 |
INTC Intel | $42.71 +0.2% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 1/23/2024 |
TXN Texas Instruments | $169.21 -1.9% | 1/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 1/23/2024 |
TER Teradyne | $102.86 -0.2% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/23/2024 |
KLAC KLA | $690.70 +1.0% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/23/2024 |
STX Seagate Technology | $85.39 -0.7% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 1/23/2024 |
LRCX Lam Research | $925.28 +1.7% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $830.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/23/2024 |
QCOM QUALCOMM | $166.92 -0.2% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 1/23/2024 |
MRVL Marvell Technology | $67.20 +0.5% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $80.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 1/23/2024 |
NXPI NXP Semiconductors | $236.62 -0.4% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $260.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 1/23/2024 |
MU Micron Technology | $93.78 +0.6% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 1/23/2024 |
GFS GLOBALFOUNDRIES | $52.10 +0.4% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $70.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 1/23/2024 |
NVDA NVIDIA | $884.55 +0.7% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $775.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/23/2024 |
AVGO Broadcom | $1,237.24 +0.1% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 1/23/2024 |
ASML ASML | $941.34 +0.1% | 1/23/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ASML (NASDAQ:ASML) on 1/23/2024 |
AMAT Applied Materials | $200.73 +1.0% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 1/23/2024 |
ADI Analog Devices | $191.22 -2.0% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 1/23/2024 |
AMD Advanced Micro Devices | $190.65 -0.2% | 1/23/2024 | Initiated by | Cantor Fitzgerald | Analyst C. Muse | Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 1/23/2024 |
BBIO BridgeBio Pharma | $27.81 +0.9% | 1/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 1/22/2024 |
AXSM Axsome Therapeutics | $72.54 -4.0% | 1/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/22/2024 |
RIOT Riot Platforms | $11.43 -1.5% | 1/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 1/22/2024 |
CI The Cigna Group | $352.63 +0.2% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $334.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 1/19/2024 |
ELV Elevance Health | $511.31 -0.3% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $547.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/19/2024 |
HCA HCA Healthcare | $327.18 +1.6% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $315.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 1/19/2024 |
HUM Humana | $347.19 -0.3% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $597.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 1/19/2024 |
UNH UnitedHealth Group | $487.08 -0.8% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 1/19/2024 |
NNOX Nano-X Imaging | $11.38 +5.6% | 1/19/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 1/19/2024 |
RCEL AVITA Medical | $15.83 -3.7% | 1/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $22.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 1/19/2024 |
AXGN AxoGen | $7.71 +0.4% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $12.00 | Low | View details for Cantor Fitzgerald rating of AxoGen (NASDAQ:AXGN) on 1/19/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 1/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $114.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/19/2024 |
ENVX Enovix | $7.33 -6.5% | 1/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 1/18/2024 |
ALNY Alnylam Pharmaceuticals | $147.41 -1.2% | 1/18/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/18/2024 |
KRTX Karuna Therapeutics | $329.83
| 1/17/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $330.00 | Low | View details for Cantor Fitzgerald rating of Karuna Therapeutics (NASDAQ:KRTX) on 1/17/2024 |
ZVRA Zevra Therapeutics | $5.96 -0.7% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/12/2024 |
ZLAB Zai Lab | $18.08 -2.1% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 1/12/2024 |
THTX Theratechnologies | $1.23 -2.4% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Theratechnologies (NASDAQ:THTX) on 1/12/2024 |
TH Theratechnologies | C$1.66 -1.8% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Theratechnologies (TSE:TH) on 1/12/2024 |
ONC Oncolytics Biotech | C$1.42 +6.0% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Oncolytics Biotech (TSE:ONC) on 1/12/2024 |
SMRT SmartRent | $2.70
| 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | | Low | View details for Cantor Fitzgerald rating of SmartRent (NYSE:SMRT) on 1/12/2024 |
SCYX SCYNEXIS | $1.44 -0.7% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 1/12/2024 |
PRCH Porch Group | $3.59 +3.5% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Siegler | Overweight | | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 1/12/2024 |
PDSB PDS Biotechnology | $4.76 -3.1% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 1/12/2024 |
PCVX Vaxcyte | $68.04 -2.4% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 1/12/2024 |
ONCY Oncolytics Biotech | $1.04 +5.1% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Oncolytics Biotech (NASDAQ:ONCY) on 1/12/2024 |
NVO Novo Nordisk A/S | $132.89 +0.4% | 1/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 1/12/2024 |